A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use ...
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could also have a ...
For thousands of families, the Sept. 11 attack did not end when the fires were extinguished. It simply changed form,” writes ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of wastewater ...
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...
An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results